Navigation Links
ULURU Inc. Announces Conference Call to Discuss Financial Results for the Second Quarter Ended June 20, 2011 and to Provide a Business Update
Date:8/11/2011

ADDISON, Texas, Aug. 11, 2011 /PRNewswire/ -- ULURU Inc. (NYSE AMEX: ULU) today announced that it has scheduled a conference call to discuss the second quarter ended June 30, 2011 financial results and to provide a general business update on Tuesday, August 16, 2011 at 9:00 a.m. Eastern Time.

To participate in the conference call please dial (800) 357-0498, for international callers dial (850) 429-1388 (access code 23818#) five to ten minutes prior to the initiation of the teleconference. If you are unable to listen to the live broadcast, a replay of the call will be available starting on August 16, 2011 two hours following the end of the call until August 23, 2011 at 11:59 p.m. Eastern Time. For the U.S. replay, please dial (866) 415-9493 for international callers dial (585) 419-6446 (access code 23818#). You may also access the replay of the call two hours following the end of the call until August 23, 2011 at 11:59 p.m. Eastern Time via the web by logging onto http://app.replayrecorder.com/multipoint/.

About ULURU Inc.:

ULURU Inc. is a specialty pharmaceutical company focused on the development of a portfolio of wound management and oral care products to provide patients and consumers with improved clinical outcomes through controlled delivery utilizing its innovative Nanoflex® Aggregate technology and OraDisc™ transmucosal delivery system. For more information about ULURU Inc., please visit www.uluruinc.com. For more information about Altrazeal®, please visit www.Altrazeal.com.

This press release contains certain statements that are forward-looking within the meaning of Section 27a of the Securities Act of 1933, as amended. These statements are subject to numerous risks and uncertainties
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ULURU Inc. Announces the Commencement of First Clinical Study Using Altrazeal(TM) Silver
2. ULURU Inc. to Present Altrazeal(TM) Clinical Evidence and Advanced Therapeutic Research at the Diabetic Foot Global Conference (DFCon) 2009
3. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Third Quarter Ended September 30, 2009 and to Provide a Business Update
4. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
5. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
6. ULURU Inc. Reports Second Quarter 2010 Financial Results
7. ULURU Inc. Announces Conference Call
8. ULURU Inc. Provides Altrazeal® Clinical Update
9. ULURU Inc. Reports Third Quarter 2010 Financial Results
10. ULURU Inc. to Raise $500,000 in Registered Direct Offering
11. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... Aug. 20, 2014   Ventana Medical Systems, ... today announced that its VENTANA System for Primary ... the European Union for routine pathology, including primary ... of VENTANA Virtuoso software coupled with either the ... slide scanner, provides automated digital slide creation, case ...
(Date:8/20/2014)... -- Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, ... FDA (CFDA) approval and has subsequently launched its ... China domestic market.  Under the ... Sinochem Jiangsu Pharmaceutical Co., Ltd., Amerigen is manufacturing ... China CFDA certified oral solid dose facility in ...
(Date:8/20/2014)... , Aug. 20, 2014 Reportlinker.com ... available in its catalogue: The Market ... http://www.reportlinker.com/p02051938/The-Market-for-Medical-Devices-in-EMEA .html The European, Middle Eastern and ... medical devices. As part of its coverage, this ... concentrates on the EMEA medical device markets and ...
Breaking Medicine Technology:Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 2Full digitization of the anatomic pathology lab is here with the VENTANA System for Primary Diagnosis 3Amerigen Pharmaceuticals Ltd. announces that its Chinese subsidiary, Suzhou Amerigen Pharmaceuticals Co. Ltd., has received Chinese FDA (CFDA) approval and has subsequently launched its generic Mecobalamin 0.5 mg Tablets into the China domestic mark 2The Market for Medical Devices in EMEA 2The Market for Medical Devices in EMEA 3The Market for Medical Devices in EMEA 4The Market for Medical Devices in EMEA 5
... at the , 2007 American Society of Clinical ... Patients with AML and in,Refractory , ALL Patients ... Aloxi(R),with , the 5-HT3 Receptor Reported-- , --Results ... with Multimodal Therapy, including Gliadel(R) Described-- , --Survival ...
... June 05, 2007 /PRNewswire-USNewswire/ -- The Barbara,Ann Karmanos ... of medicine and oncology, presented the outcome,of one ... clinical,trials in North America and chaired an education ... the American Society of,Clinical Oncology (ASCO) annual meeting ...
Cached Medicine Technology:MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 2MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 3MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 4MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 5MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 6MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 7MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 8MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 9MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting 10Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 2Clinical Trial Results Change Standard of Care for Pancreatic,Cancer Patients, Future Therapies Discussed 3
(Date:8/20/2014)... Verndale is pleased to announce their recent ... list ranking the fastest-growing private companies in America. The ... yearly percentage revenue growth over a three-year period. For ... 5000 list where it ranked number 2,855. , As ... a wide range of digital marketing services including core ...
(Date:8/20/2014)... North Carolina (PRWEB) August 20, 2014 ... , findings from a University College London (UCL) study ... disagreed on what method of brushing teeth was the ... found that six different tooth-brushing techniques were frequently recommended, ... the Charlotte Center for Cosmetic Dentistry, experienced cosmetic ...
(Date:8/20/2014)... 20, 2014 Oxnard dentist ... the Anacapa Dental Art Institute, is presenting at the ... will be speaking on All-on-4 dental implants ... Graft Less Solutions” at 12:40 p.m. Sept. 20 at ... British Columbia, Canada. , “The All-on-4 procedure gives patients ...
(Date:8/20/2014)... 20, 2014 Biosimilars, which are ... approved through an abbreviated process, could reap billions ... Atlantic Information Services, Inc.’s (AIS) Specialty Pharmacy News ... including the Food and Drug Administration’s (FDA) recent ... towards approval. , Drugmaker Sandoz said July 24 ...
(Date:8/20/2014)... 20, 2014 No matter how “lonely” a ... a steady set of friends to be always there for ... to the concept of making new friends during adulthood ... ranging from taking care of one’s family to a near-slavish ... to a new person just is not the same as ...
Breaking Medicine News(10 mins):Health News:For the 8th Time, Verndale Has Been Honored on the Inc. 5000 List 2Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 2Health News:Internationally Known Oxnard Dentist to Speak at Conference in Vancouver 3Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 2Health News:AIS Newsletter Tracks Latest Developments in Biosimilars Market as FDA Accepts First Application 3Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2
... the psychiatrist Dr Charles Reynolds at the University of Pittsburgh ... , The study’s main aim was to analyze ... elderly people. It is one of the longest studies ... prescribe antidepressants for longer periods, perhaps even for life, in ...
... Department of New South Wales has conducted a study which ... the user's physical health// . , It is ... Cannabis abuse can lead to cardiovascular, respiratory and immune system ... slow brain development at a young age. New South Wales ...
... Yale shed new light on the mechanism of nerve ... "motor" protein, myosin-II, according to an //article in the ... develop or attempt to recover after damage, they extend ... sensors. Growth cones use the information they gather to ...
... shorts in football prints and innerwear with net inserts ... lingerie designers are experimenting with.,Overall, the trend in lingerie ... with a hint of romance. The seductive undergarments require ... being tried with embroidery. The garments aren't so opulent, ...
... overcrowding of farm owners in local veterinary centres has created much ... Nadub //. The deadly avian influenza virus outbreak in India was ... 20 chickens dropped dead Saturday in Manakkad area of Salem district, ... for tests. ,Tamil Nadu has been on high alert ...
... pain by taking Oxycontin, a prescription painkiller. Later on for ... cheaper option. // Michaud, now 18 years is one ... prescription drugs. Teenagers are increasingly experimenting with legal drugs like ... from medicine cabinets. , Health officials say that ...
Cached Medicine News:Health News:Drugs Are Effective In Treating Depression and Preventing Recurrence 2Health News:A New Focus For The Mechanism Of Nerve Growth 2Health News:Romantic and discreet trends in lingerie 2Health News:New Generation Teenagers Addiction to Prescription Drugs 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: